Trial · NCT01097421
Results by group26
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 26
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Patients With a Score of 4 in Morisky Scale After 8-12 Weeks of Treatment | Pramipexole Extended Release | 75.2 | 95% Confidence Interval (70.1, 79.8) | Percent | |
| Level of Adherence | Pramipexole Extended Release | Low Adherence | 4 | Participants | |
| Level of Adherence | Pramipexole Extended Release | Moderate Adherence | 77 | Participants | |
| Level of Adherence | Pramipexole Extended Release | High Adherence | 245 | Participants | |
| Patient Preference | Pramipexole Extended Release | Once daily intake | 284 | Participants | |
| Patient Preference | Pramipexole Extended Release | Three times daily intake | 18 | Participants | |
| Patient Preference | Pramipexole Extended Release | No difference | 24 | Participants | |
| Adverse Events (AE) Considered Related to Observed Medication | Pramipexole Extended Release | related | 20 | Patients | |
| Adverse Events (AE) Considered Related to Observed Medication | Pramipexole Extended Release | not related | 21 | Patients | |
| Adverse Events (AE) Considered Related to Observed Medication | Pramipexole Extended Release | total AE - related and not related | 39 | Patients | |
| Pramipexole (PPX) Dose | Pramipexole Extended Release | pre-treatment immediate release dose | 1.07 | Standard Deviation 0.73 | mg/24 hr |
| Pramipexole (PPX) Dose | Pramipexole Extended Release | extended release dose at final observation | 1.05 | Standard Deviation 0.75 | mg/24 hr |
| Clinical Global Impressions (CGI) | Pramipexole Extended Release | Very much improved | 0 | Participants | |
| Clinical Global Impressions (CGI) | Pramipexole Extended Release | Much improved | 38 | Participants | |
| Clinical Global Impressions (CGI) | Pramipexole Extended Release | Minimally improved | 106 | Participants | |
| Clinical Global Impressions (CGI) | Pramipexole Extended Release | No change | 149 | Participants | |
| Clinical Global Impressions (CGI) | Pramipexole Extended Release | Minimally worse | 26 | Participants | |
| Clinical Global Impressions (CGI) | Pramipexole Extended Release | Much worse | 7 | Participants | |
| Clinical Global Impressions (CGI) | Pramipexole Extended Release | Very much worse | 0 | Participants | |
| Patients Global Impressions (PGI) | Pramipexole Extended Release | Very much improved | 3 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01097421/results